Heartbeam Ownership

BEAT Stock  USD 2.25  0.08  3.69%   
Heartbeam has a total of 26.67 Million outstanding shares. Heartbeam secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2006-03-31
Previous Quarter
26.6 M
Current Value
26.8 M
Avarage Shares Outstanding
22.1 M
Quarterly Volatility
10.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Dividend Paid And Capex Coverage Ratio is likely to gain to -51.61 in 2025. Common Stock Shares Outstanding is likely to drop to about 19.1 M in 2025. Net Loss is likely to gain to about (11.1 M) in 2025.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Heartbeam. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.

Heartbeam Stock Ownership Analysis

About 29.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Heartbeam recorded a loss per share of 0.68. The entity had not issued any dividends in recent years. HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. For more info on Heartbeam please contact the company at 408 899 4443 or go to https://www.heartbeam.com.
Besides selling stocks to institutional investors, Heartbeam also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Heartbeam's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Heartbeam's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Heartbeam Quarterly Liabilities And Stockholders Equity

6.66 Million

Heartbeam Insider Trades History

About 29.0% of Heartbeam are currently held by insiders. Unlike Heartbeam's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Heartbeam's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Heartbeam's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Heartbeam Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Heartbeam is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Heartbeam backward and forwards among themselves. Heartbeam's institutional investor refers to the entity that pools money to purchase Heartbeam's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Street Corp2024-09-30
69.6 K
Pasadena Private Wealth, Llc2024-09-30
60.6 K
Spectrum Asset Management Inc2024-09-30
54.4 K
Advisory Research Inc2024-09-30
50 K
Northern Trust Corp2024-09-30
46.8 K
D'orazio & Associates Inc2024-09-30
33 K
Two Sigma Securities, Llc2024-09-30
23.9 K
Xtx Topco Ltd2024-09-30
14.6 K
Charles Schwab Investment Management Inc2024-09-30
14.5 K
Vanguard Group Inc2024-09-30
750.7 K
Smith, Salley & Associates, Llc2024-09-30
250 K
Note, although Heartbeam's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Heartbeam Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heartbeam insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heartbeam's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heartbeam insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Heartbeam Outstanding Bonds

Heartbeam issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Heartbeam uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Heartbeam bonds can be classified according to their maturity, which is the date when Heartbeam has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Heartbeam Corporate Filings

FWP
8th of January 2025
A written communication used by offering participants to offer securities to the public or to solicit securities transactions.
ViewVerify
23rd of December 2024
Other Reports
ViewVerify
10Q
7th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
23rd of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heartbeam Stock Analysis

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.